Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...

Friday, researchers presented phase 2 data on the combination at the European Lung Cancer Congress (ELCC). As of the December cutoff, 48 patients in the open-label, single-arm trial had completed ...

Suresh Senan, PhD, radiation oncologist at the Amsterdam University Medical Centers, The Netherlands, and principal investigator in the trial, said: “This approval marks a turning point for patients ...